Abstract
Natural products have had an important and decisive role in the development of modern medicinal chemistry and drug design. The development of new bioassay techniques, biotech methods, bio-guided phytochemical studies, automated high-throughput screening, and high performance analytical methods has introduced both new concepts and possibilities for rational drug design and drug discovery. With the development of new spectroscopic techniques, organic chemists have been able to elucidate the complex molecular structures of natural constituents quickly. Secondary metabolites, namely, alkaloids, flavonoids, and terpenoids as anticancer molecules, involving various strategies of treatment, have been discussed with special reference to topoisomerases (Topo), cyclooxygenases (COX), lipoxygenase (LOX), and aromatase as enzymatic targets for various types of cancers. In silico methods or CADD (computer-aided drug design) studies are increasingly being used in both industries and universities. They involve an understanding of the molecular interactions from both qualitative and quantitative points of view. These methods generate and manipulate three-dimensional (3D) molecular structures, calculate descriptors and the dependent molecular properties, model constructions, and employ other tools that encompass computational drug research. Analysis of the molecular structure of a given system allows relevant information to be extracted and to predict the potential of bioactive compounds. Furthermore, in view of the recent advances made in the field of computer-aided drug design, the aim of present chapter is to discuss the use of computational approaches such as ADMET, molecular docking, molecular dynamics simulation, and QSAR to asses and predict the safety, efficacy, potency, and identification of natural potent anticancer molecules.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aggarwal BB, Vijayalekshmi RV, Sung B (2009) Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res 15:425–430
Ahmedin Jemal D, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
Anjos JV, Srivastava RM, Costa-Silva JH, Scotti L, Scotti MT, Wanderley AG, Leite ES, Melo SJ, Junior FJ (2012) Comparative computational studies of 3,4-dihydro-2,6-diaryl-4-oxo-pyrimidine-5-carbonitrile derivatives as potential antinociceptive agents. Molecules 17:809–819
Brastianos HC, Sturgeon CM, Roberge M, Andersen RJ (2007) Inhibition of the G2 DNA damage checkpoint by oliveroline isolated from Duguetia odorata. J Nat Prod 70:287–288
Brown DG, Lister T, May-Dracka TL (2014) New natural products as new leads for antibacterial drug discovery. Bioorg Med Chem Lett 24:413–418
Burgeiro A, Gajate C, Dakir EH, Villa-Pulgarín JA, Oliveira PJ, Mollinedo F (2011) Involvement of mitochondrial and B-RAF/ERK signaling pathways in berberine-induced apoptosis in human melanoma cells. Anti-Cancer Drugs 22:507–518
Camacho KM, Kumar S, Menegatti S, Vogus DR, Anselmo AC, Mitragotri S (2015) Synergistic antitumor activity of camptothecin-doxorubicin combinations and their conjugates with hyaluronic acid. J Control Release 210:198–207
Campos HC, da Rocha MD, Viegas FPD, Nicastro PC, Fossaluzza PC, Fraga CA, Barreiro EJ, CJr V (2011) The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders I: Parkinson’s disease. CNS Neurol Disord-Drug Targets 10:239–250
Chalabi N, Satih S, Delort L, Bignon YJ, Bernard-Gallon DJ (2007) Expression profiling by whole genome microarray hybridization reveals differential gene expression in breast cancer cell lines after lycopene exposure. Biochim Biophys Acta 1769:124–130
Chan JYY, Yuen ACY, Chan RYK, Chan SW (2013) A review of the cardiovascular benefits and antioxidant properties of Allicin. Phytother Res 27:637–646
Charifson PS, Walters WP (2014) Acidic and basic drugs in medicinal chemistry: a perspective. J Med Chem 57:9701–9717
Cheah YH, Nordin FJ, Tee TT, Azimahtol HL, Abdullah NR, Ismail Z (2008) Antiproliferative property and apoptotic effect of xanthorrhizol on MDA-MB-231 breast cancer cells. Anticancer Res 28:3677–3689
Chen YZ, Li ZR, Ung CY (2002) Computational method for drug target search and application in drug discovery. J Theor Comput Chem 1:213–224
Chen BH, Chang HW, Huang HM, Chong IW, Chen JS, Chen CY, Wang HM (2011) (−)-Anonaine induces DNA damage and inhibits growth and migration of human lung carcinoma h1299 cells. J Agric Food Chem 59:2284–2290
Chrea B, O’Connell JA, Silkstone-Carter O, O’Brien J, Walsh JJ (2014) Nature’s antidepressant for mild to moderate depression: isolation and spectral characterization of hyperforin from a standardized extract of St. John’s wort (Hypericum perforatum). J Chem Educ 91:440–442
Clement JA (2014) Recent progress in medicinal natural products drug discovery. Curr Top Med Chem 14:2758
Cohen NC (1996) Guidebook on molecular modeling in drug design. Academic Press, San Diego
Congur G, Erdem A, Mese F (2015) Electrochemical investigation of the interaction between topotecan and DNA at disposable graphite electrodes. Bioelectrochemistry 102:21–28
Cragg G, Newman D (2014) Natural products and drug discovery and development: a history of success and continuing promise for the future. Planta Med 80:750. https://doi.org/10.1055/s-0034-1382292
Cui L, Ni X, Qian J, Teng X, Yang Y, Wu C, Zekria D, Zhang D, Kai G (2015) Co-overexpression of geraniol-10-hydroxylase and strictosidine synthase improves anti-cancer drug camptothecin accumulation in Ophiorrhiza pumila. Sci Rep 5:1–9
da Rocha MD, Viegas FPD, Campos HC, Nicastro PC, Fossaluzza PC, Fraga CA, Barreiro EJ, Viegas C Jr (2011) The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders II: Alzheimer’s disease. CNS Neurol Disord Drug Targets 10:251–270
da Silva MS, Tavares JF, Queiroga KF, Agra MD, Barbosa JM, Alimeida J, da Silva SAS (2009) Alkaloids and other constituents from Xylopia langsdorffiana (Annonaceae). Quim Nova 32:1566–1570
Dave K, Panchal H (2012) Review on chemogenomics approach: interpreting antagonist activity of secreted frizzled-related protein 1 in glaucoma disease with in silico docking. Curr Top Med Chem 12:1834–1842
de Araújo RS, Guerra FQ, de O Lima E, De Simone CA, Tavares JF, Scotti L, Scotti MT, De Aquino TM, De Moura RO, Mendonça FJ, Barbosa-Filho JM (2013) Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity. Int J Mol Sci 14:1293–1309
de Atenção BC (2013) Controle dos cânceres do colo do útero e da mama, 2nd edn. Ministério da Saúde, Brasília
de Avila MB, de Azevedo WF (2014) Data mining of docking results. Application to 3-dehydroquinate dehydratase. Curr Bioinforma 9:361–379
Decker M (2011) Hybrid molecules incorporating natural products: applications in cancer therapy, neurodegenerative disorders and beyond. Curr Med Chem 18:1464–1475
Devi RV, Sathya SS, Selvaraj M (2015) Evolutionary algorithms for de novo drug design – a survey. Appl Soft Comput J 27:543–552
Dewar MJSE, Zoebisch G, Healy EF, Stewart JJPAM (1985) A new general purpose quantum mechanical molecular model. J Am Chem Soc 107:3902–3909
Ding XT, Matsuo K, Xu L, Yang J, Zheng LP (2015) Optimized combinations of bortezomib, camptothecin, and doxorubicin show increased efficacy and reduced toxicity in treating oral cancer. Anti-Cancer Drugs 26:547–554
Duffy R, Wade C, Chang R (2012) Discovery of anticancer drugs from antimalarial natural products: a MEDLINE literature review. Drug Discov Today 17:942–953
Echenique P, Alonso JL (2007) A mathematical and computational review of Hartree-Fock SCF methods in quantum chemistry. Mol Phys 105:3057–3098
Fiorani P, Amatruda JF, Silvestri A, Butler RH, Bjornsti A, Benedetti P (1999) Domain interactions affecting human DNA topoisomerase I catalysis and camptothecin sensitivity. Mol Pharmacol 56:1105–1115
Fortune JM, Osheroff N (2000) Topo II as a target for anticancer drugs: when enzymes stop being nice. Proc Nucleic Acid Res Mol Biol 64:221–253
Frampton CS (2013) An introduction to the special issue on pharmaceuticals, drug discovery and natural products. Acta Crystallogr Sect C 69:1205–1206
Graille M, Cladiere L, Durand D, Lecointe F, Gadelle D, Quevillon-Cheruel S, Vachette P, Forterre P, van Tilbeurgh H (2008) Crystal structure of an intact type II DNA topoisomerase: insights into DNA transfer mechanisms. Structure 16:360–370
Grivennikov SI, Greten FR, Karin M (2011) Immunity, inflammation, and cancer. Cell 140:883–899
Grunnet M, Calatayud D, Schultz NA, Hasselby JP, Mau-Sørensen M, Brünner N, Stenvang J (2015) TOP1 gene copy numbers are increased in cancers of the bile duct and pancreas. Scand J Gastroenterol 50:485–494
Hande KR (1998) Etoposide: four decades of development of a topo II inhibitor. Eur J Cancer 34:1514–1521
Hatae N, Fujita E, Shigenobu S, Shimoyama S, Ishihara Y, Kurata Y, Choshi T, Nishiyama T, Okada C, Hibino S (2015) Antiproliferative activity of O-4-benzo c phenanthridine alkaloids against HCT-116 and HL-60 tumor cells. Bioorg Med Chem Lett 25:2749–2752
Houghton PJ, Cheshire PJ, Myers L, Stewart CF, Synold TW, Houghton JA (1991) Evaluation of 9-dimethylaminomethyl-10 hydroxy-camptothecin (topotecan) against xenografts derived from adult and childhood tumors. Cancer Chemother Pharmacol 31:229–239
Ishiki H, Junior FJ, Santos PF, Tavares JF, Silva MS, Scotti MT (2014) Theoretical research into anticancer activity of diterpenes isolated from the paraiban flora. Nat Prod Commun 9:911–914
Jeong HJ, Shin YG, Kim IH, Pezzuto JM (1999) Inhibition of aromatase activity by flavonoids. Arch Pharm Res 22:309–312
Kakarala M, Brenner DE, Korkaya H, Cheng C, Tazi K, Ginestier C, Liu S, Dontu G, Wicha MS (2010) Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res Treat 122:777–785
Kanzawa F, Koizumi F, Koh Y, Nakamura T, Tatsumi Y, Fukumoto H, Saijo N, Yoshioka T, Nishio K (2001) In vitro synergistic interactions between the cisplatin analogue nedaplatin and the DNA topoisomerase I inhibitor irinotecan and the mechanism of this interaction. Clin Cancer Res 7:202–209
Karioti A, Milosevic-Ifantis T, Pachopos N, Niryiannaki N, Hadjipavlou-Litina D, Skaltsa H (2015) Antioxidant, anti-inflammatory potential and chemical constituents of Origanum dubium Boiss., growing wild in Cyprus. J Enzym Inhib Med Chem 30:38–43
Kennedy DA, Hart J, Seely D (2009) Cost effectiveness of natural health products: a systematic review of randomized clinical trials. Evidence-Based Compl Altern Med 6:297–304
Konkimalla BV, Efferth T (2010) Inhibition of epidermal growth factor receptor over-expressing cancer cells by the aphorphine-type isoquinoline alkaloid, dicentrine. Biochem Pharmacol 79:1092–1099
Kothandan G, Ganapathy J (2014) A short review on the application of combining molecular docking and molecular dynamics simulations in field of drug discovery. J Chosun Nat Sci 7:75–78
Kumar NDR, George CV, Kumar SP, Kumar AR (2012) Cytotoxicity, apoptosis induction and anti-metastatic potential of Oroxylum indicum in human breast cancer cells. Asian Pac J Cancer Prev 13:2729–2734
Laco GS, Collins JR, Luke BT, Kroth H, Sayer JM, Jerina DM, Pommier Y (2002) Human topoisomerase I inhibition: docking camptothecin and derivatives into a structure-based active site model. Biochemistry 41:1428–1435
Lavecchia A, Di Giovanni C (2013) Virtual screening strategies in drug discovery: a critical review. Curr Med Chem 20:2839–2860
Leach AR (2001) Molecular modeling: principles and applications. Prentice Hall, London
Li Z, Wang Y, Mo B (2002) The effects of carotenoids on the proliferation of human breast cancer cell and gene expression of bcl-2. Zhonghua Yu Fang Yi Xue Za Zhi 36:254–257
Liu YC, Chen ZF, Liu LM, Peng Y, Hong X, Yang B, Liu HG, Liang H, Orvig C (2009) Divalent later transition metal complexes of the traditional Chinese medicine (TCM) liriodenine: coordination chemistry, cytotoxicity and DNA binding studies. Dalton Trans 48:10813–10823
Liu YQ, Li WQ, Morris-Natschke SL, Qian KD, Yang L, Zhu GX, Wu XB, Chen AL, Zhang SY, Nan X, Lee KH (2015) Perspectives on biologically active camptothecin derivatives. Med Res Rev 35:753–789
Lu JJ, Bao JL, Chen XP, Huang M, Wang YT (2012) Alkaloids isolated from natural herbs as the anticancer agents. Evidence-Based Compl Altern Med 2012:485042
Millimouno FM, Dong J, Yang L, Li J, Li X (2014) Targeting apoptosis pathways in cancer and perspectives with natural compounds from mother nature. Cancer Prev Res 7:1081–1107
Mills E, Wu P, Johnston BC, Gallicano K, Clarke M, Guyatt G (2005) Natural health product-drug interactions -a systematic review of clinical trials. Ther Drug Monit 27:549–557
Mishra KP, Ganju L, Sairam M, Banerjee PK, Sawhney RC (2008) A review of high throughput technology for the screening of natural products. Biomed Pharmacother 62:94–98
Moran M, Guzman J, Ropars A-L, McDonald A, Jamerson N, Omune B, Ryan S, Wu L (2009) Neglected disease research and development: how much are we really spending. PLoS Med 6:137–146
Morris GM, Lim-Wilby M (2008) Molecular docking. Methods Mol Biol 443:365–382
Motohashi Y, Igarashi M, Okamatsu M, Noshi T, Sakoda Y, Yamamoto N, Ito K, Yoshida R, Kida H (2013) Antiviral activity of stachyflin on influenza: a viruses of different hemagglutinin subtypes. Virol J 10:118. https://doi.org/10.1186/1743-422X-10-118
Mukherjee AK, Basu S, Sarkar N, Ghosh AC (2001) Advances in cancer therapy with plant based natural products. Curr Med Chem 8:1467–1486
Pita JC, Xavier AL, Sousa TK, Mangueira VM, Tavares JF, Júnior RJ, Veras RC, Pessoa HD, Silva MS, Morelli S, Ávila VD (2012) In vitro and in vivo antitumor effect of trachylobane-360, a diterpene from Xylopia langsdorffiana. Molecules 17:9573–9589
Polo MP, Bravo D (2006) Effect of geraniol on fatty-acid and mevalonate metabolism in the human hepatoma cell line Hep G2. Biochem Cell Biol 84:102–111
Prescott TA, Sadler IH, Kiapranis R, Maciver SK (2007) Lunacridine from Lunasia amara is a DNA intercalating topoisomerase II inhibitor. J Ethnopharmacol 109:289–294
Qurishi Y, Hamid A, Zargar MA, Singh SK, Saxena AK (2010) Potential role of natural molecules in health and disease: importance of boswellic acid. J Med Plant Res 4:2778–2785
Safarzadeh E, Shotorbani SS, Baradaran B (2014) Herbal medicine as inducers of apoptosis in cancer treatment. Adv Pharm Bull 4:421–427
Sagar SM, Yance D, Wong RK (2006) Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-part 1. Curr Oncol 13:14–26
Scotti L, Scotti MT, Lima ED, da Silva MS, de Lima MDA, Pitta ID, de Moura RO, de Oliveira JGB, da Cruz RMD, Mendonca FJB (2012a) Experimental methodologies and evaluations of computer-aided drug design methodologies applied to a series of 2-aminothiophene derivatives with antifungal activities. Molecules 17:2298–2315
Scotti L, Mendonça Junior FJB, Moreira DRM, Silva MS, da Pitta IR, Scotti MT (2012b) SAR, QSAR and docking of anticancer flavonoids and variants: a review. Curr Top Med Chem 12:2785–2809
Scotti L, Scotti MT, Ishiki H, Junior FJ, Tavares JF, da Silva MS (2014) Prediction of anticancer activity of diterpenes isolated from the Paraiban flora through a Pls model and molecular surfaces. Nat Prod Commun 9:609–612
Shekhar C (2008) In Silico pharmacology: computer-aided methods could transform drug development. Chem Biol 15:413–414
Sonderstrup IM, Nygård SB, Poulsen TS, Linnemann D, Stenvang J, Nielsen HJ, Bartek J, Brünner N, Nørgaard P, Riis L (2015) Topoisomerase-1 and-2A gene copy numbers are elevated in mismatch repair-proficient colorectal cancers. Mol Oncol 9:1207–1217
Souza B, De Oliveira T, Aquino T, de Lima M, Pitta I, Galdino S, Lima E, Gonçalves-Silva T, Militão G, Scotti L, Scotti M (2012) Preliminary antifungal and cytotoxic evaluation of synthetic cycloalkyl b thiophene derivatives with PLS-DA analysis. Acta Pharma 62:221–236
Staker BL, Feese MD, Cushman M, Pommier Y, Zembower D, Stewart L, Burgin AB (2005) Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex. J Med Chem 48:2336–2345
Talele TT, Khedkar S, Rigby AC (2010) Successful applications of computer aided drug discovery: moving drugs from concept to the clinic. Curr Top Med Chem 10:127–141
Tan W, Lu J, Huang M, Li Y, Chen M, Wu G, Gong J, Zhong Z, Xu Z, Dang Y, Guo J, Chen X, Wang J (2011) Anticancer natural products isolated from chinese medicinal herbs. J Chin Med 6:27. https://doi.org/10.1186/1749-8546-6-27
Tan G, Yao Y, Gu Y, Li S, Lv M, Wang K, Chen H, Li X (2014) Cytotoxicity and DNA binding property of the dimers of triphenylethylene-coumarin hybrid with one amino side chain. Bioorg Med Chem Lett 24:2825–2830
Tang XJ, Han M, Yang B, Shen YQ, He ZG, Xu DH, Gao JQ (2014) Nanocarrier improves the bioavailability, stability and antitumor activity of camptothecin. Int J Pharm 477:536–545
Tavares JF, Queiroga KF, Silva MVB, Diniz M, Barbosa-Filho JM, da Cunha EVL, de Simone CA, de Araujo JX, Melo PS, Haun M, da Silva MS (2006) ent-trachylobane diterpenoids from Xylopia langsdorffiana. J Nat Prod 69:960–962
Taylor RD, Jewsbury PJ, Essex JW (2002) A review of protein-small molecule docking methods. J Comput Aided Mol Des 16:151–166
Thoppil RJ, Bishayee A (2011) Terpenoids as potential chemopreventive and therapeutic agents in liver cancer. World J Hepatol 3:228–249
Tu X, Wang L, Cao Y, Ma Y, Shen H, Zhang M, Zhang Z (2016) Efficient cancer ablation by combined photothermal and enhanced chemotherapy based on carbon nanoparticles/doxorubicin@SiO2 nanocomposites. Carbon 97:35–44
Vipin AM, Baby B, Kumar MS, Ravisankar V, Nazeem PA (2015) Comparative docking studies on the effect of commercial drugs on dipeptidyl peptidase-4 (DPP-4). Int J Pharm Pharm Sci 7:508–510
von Pawel J, Jotte R, Spigel DR, O’Brien ME, Socinski MA, Mezger J, Steins M, Bosquée L, Bubis J, Nackaerts K, Trigo JM (2014) Randomized phase III trial of amrubicin versus topotecan as second-line treatment for patients with small-cell lung cancer. J Clin Oncol 32:4012–4019
Wang BC, Deng J, Gao YM, Zhu LC, He R, Xu YQ (2011) The screening toolbox of bioactive substances from natural products: a review. Fitoterapia 82:1141–1151
Wang CZ, Calway T, Yuan CS (2012) Herbal medicines as adjuvants for cancer therapeutics. Am J Chin Med 40:657
Wheat J, Currie G (2008) Herbal medicine for cancer patients: an evidence based review. Int J Altern Med 5:1–11
Yang H, Dou QP (2010) Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer. Curr Drug Targets 11:733–744
Yang ZR, Liu M, Peng XL, Lei XF, Zhang JX, Dong WG (2012) Noscapine induces mitochondria-mediated apoptosis in human colon cancer cells in vivo and in vitro. Biochem Biophys Res Commun 421:627–633
Yeo CD, Lee SH, Kim JS, Kim SJ, Kim SC, Kim YK, Kang HH, Yoon HK, Song JS, Moon HS, Kim JW (2013) A multicenter phase II study of belotecan, a new camptothecin analogue, in elderly patients with previously untreated, extensive-stage small cell lung cancer. Cancer Chemother Pharmacol 72:809–814
Yuriev E, Ramsland P (2013) Latest developments in molecular docking: 2010–2011 in review. J Mol Recognit 26:215–239
Zhu M, Zhou L, Yao Y, Li S, Lv M, Wang K, Li X, Chen H (2015) Anticancer activity and DNA binding property of the dimers of triphenylethylene-coumarin hybrid with two amino side chains. Med Chem Res 24:2314–2324
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Scotti, L. et al. (2018). CADD Studies Applied to Secondary Metabolites in the Anticancer Drug Research. In: Akhtar, M., Swamy, M. (eds) Anticancer Plants: Mechanisms and Molecular Interactions. Springer, Singapore. https://doi.org/10.1007/978-981-10-8417-1_9
Download citation
DOI: https://doi.org/10.1007/978-981-10-8417-1_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-8416-4
Online ISBN: 978-981-10-8417-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)